Lbp Am Sa Has $85.05 Million Position in Stryker Corporation (NYSE:SYK)

LBP AM SA lifted its stake in Stryker Corporation (NYSE:SYK - Free Report) by 11.0% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 228,469 shares of the medical technology company's stock after purchasing an additional 22,659 shares during the quarter. Stryker accounts for about 1.3% of LBP AM SA's investment portfolio, making the stock its 15th largest holding. LBP AM SA owned 0.06% of Stryker worth $85,048,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Capital A Wealth Management LLC purchased a new stake in shares of Stryker during the 4th quarter worth about $26,000. Rakuten Securities Inc. raised its stake in shares of Stryker by 618.2% during the 4th quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company's stock worth $28,000 after purchasing an additional 68 shares in the last quarter. Goodman Advisory Group LLC purchased a new stake in shares of Stryker during the 1st quarter worth about $32,000. City Holding Co. raised its stake in shares of Stryker by 528.6% during the 1st quarter. City Holding Co. now owns 88 shares of the medical technology company's stock worth $33,000 after purchasing an additional 74 shares in the last quarter. Finally, VSM Wealth Advisory LLC purchased a new stake in shares of Stryker during the 4th quarter worth about $36,000. Institutional investors and hedge funds own 77.09% of the company's stock.

Insider Activity

In other Stryker news, Director Ronda E. Stryker sold 200,000 shares of the stock in a transaction dated Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total value of $75,392,000.00. Following the completion of the sale, the director directly owned 3,417,326 shares in the company, valued at $1,288,195,208.96. This represents a 5.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 5.90% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the company. Citigroup reissued a "buy" rating and issued a $455.00 price objective (up from $443.00) on shares of Stryker in a research note on Thursday, May 22nd. Wall Street Zen lowered Stryker from a "buy" rating to a "hold" rating in a report on Friday, June 27th. Roth Mkm raised their target price on Stryker from $405.00 to $456.00 and gave the company a "buy" rating in a report on Friday, May 2nd. Evercore ISI raised their target price on Stryker from $390.00 to $415.00 and gave the company an "outperform" rating in a report on Tuesday. Finally, Needham & Company LLC reaffirmed a "buy" rating and issued a $442.00 target price on shares of Stryker in a report on Friday, March 21st. Five investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $428.55.

Stryker Price Performance

Stryker stock traded up $2.55 on Wednesday, reaching $392.05. The company's stock had a trading volume of 871,885 shares, compared to its average volume of 1,348,615. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.00 and a current ratio of 1.64. The company has a market cap of $149.64 billion, a price-to-earnings ratio of 52.98, a PEG ratio of 2.96 and a beta of 0.91. The business's fifty day moving average price is $383.81 and its 200 day moving average price is $376.67. Stryker Corporation has a twelve month low of $314.93 and a twelve month high of $406.19.

Stryker (NYSE:SYK - Get Free Report) last released its earnings results on Thursday, May 1st. The medical technology company reported $2.84 earnings per share for the quarter, topping analysts' consensus estimates of $2.73 by $0.11. The company had revenue of $5.87 billion during the quarter, compared to the consensus estimate of $5.68 billion. Stryker had a return on equity of 23.74% and a net margin of 12.31%. The firm's quarterly revenue was up 11.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.50 earnings per share. Equities analysts expect that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, July 31st. Shareholders of record on Monday, June 30th will be issued a $0.84 dividend. The ex-dividend date is Monday, June 30th. This represents a $3.36 annualized dividend and a dividend yield of 0.86%. Stryker's dividend payout ratio (DPR) is currently 45.41%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.